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Abstract 
Pain classification according to pathophysiological mechanisms has received considerable 
attention over recent years with potential use for clinical decision making. A number of 
algorithms for pain classification have been proposed. Non-specific arm pain (NSAP) is a 
poorly defined condition, which could benefit from classification according to pain 
mechanisms to improve treatment selection. This study used three previously published 
classification algorithms (heretofore called NeuPSIG, Smart, Schafer) to investigate the 
frequency of different pain classifications in NSAP and the clinical utility of these systems in 
assessing NSAP. 
Forty people with NSAP underwent a clinical examination and quantitative sensory testing. 
Findings were used to classify participants according to three algorithms. Frequency of pain 
classification including number unclassified was analysed using descriptive statistics. Inter-
observer agreement was analysed using and kappa coefficients. 
NSAP was classified as ‘unlikely neuropathic pain’ using NeuPSIG criteria, ‘peripheral 
neuropathic pain’ using Smart’s criteria and ‘peripheral nerve sensitisation’ using the 
Schafer algorithm. Two of the three algorithms allowed classification of all but one 
participant; up to 45% of participants (n=18) were categorised as mixed by the ‘Smart 
algorithm’. Inter-observer agreement was good for the ‘Schafer algorithm’ (к=0.78) and 
moderate for the ‘Smart algorithm’ (к=0.40). A kappa value was unattainable for the 
NeuPSIG algorithm but agreement was high.  
Pain classification was achievable with high inter-observer agreement for two of the three 
algorithms assessed. The third classification may be useful but requires further direction 
regarding the use of clinical criteria included. The impact on outcomes of adding a pain 






Classification of pain based on pathophysiological mechanisms has received considerable 
attention [1-9] and is increasingly used in diagnosis and management of musculoskeletal 
conditions. In musculoskeletal conditions, there is often a poor relationship between 
pathology, pain and disability [10], as well as high prevalence of undiagnosed disorders [11, 
12], suggesting the potential clinical value of mechanisms-based pain classification [1].  
In the absence of a gold standard classification, a number of mechanisms based algorithms 
have been proposed [8, 13, 14]. The classification algorithm endorsed by the Neuropathic 
Pain Special Interest Group (NeuPSIG) of the International Association for the Study of Pain 
[13, 15] classifies patients into one of four groups; Definite-, Probable-, Possible-, and  
Unconfirmed-Neuropathic pain, based on the number of corroborative signs (Figure 1). The 
‘NeuPSIG algorithm’ is a consensus document of NeuPSIG and its reliability or validity have 
not been formally tested.  
Classification criteria outlined by [8], for chronic low back pain (+/- leg pain), classifies 
patients into three groups (nociceptive-, peripheral neuropathic- and central sensitisation 
pain) (Figure 2). There is preliminary evidence for the validity of the ‘Smart classification’ 
when used in a low back pain population [8].  
The algorithm of [14] for classification of low-back related leg pain classifies patients into 
four groups (neuropathic sensitisation, denervation, peripheral nerve sensitisation and 
musculoskeletal pain) (Figure 3). The ‘Schafer algorithm’ has good inter-rater reliability [16] 
and good discriminative validity for the group ‘peripheral nerve sensitization’ [6].  
All three algorithms aim to distinguish patients who have pain with demonstrated painful 
neuropathy from those with non-neuropathic pain. The Smart classification and Schafer 
algorithm aim to further distinguish patients who have widespread sensitisation from those 
with nociceptive pain or peripheral nerve mechanosensitivity. The NeuPSIG algorithm does 
not make this distinction.   
Clinically, differentiation of pain mechanisms may influence decision making about potential 
interventions, for example, musculoskeletal pain and neuropathic pain would warrant 
different treatment approaches with manual therapy and therapeutic exercise likely more 
useful in musculoskeletal pain than in people with neuropathic pain. The clinical utility of 
classification algorithms is dependent on the ability of the algorithm to influence clinical 
decision making. To do this an algorithm must have the capacity to reliably and correctly 
assign patients without there being too many ‘unclassifiable’ cases [17].  
 
The use of a mechanisms-based pain classification system holds potential for non-specific 
arm pain (NSAP).  NSAP is a common upper limb disorder [18],that is frequently associated 
with poor outcome [19]. Whilst NSAP is a diagnosis of exclusion [20], the high prevalence of 
weakness and  paraesthesia in NSAP [21] suggests a neural tissue disorder might underpin 
some presentations of  NSAP. This hypothesis is supported by findings of altered vibration 
thresholds [22, 23] and neural tissue sensitivity [22, 24]. However, data also exist suggesting 
that a muscle tissue disorder[25, 26] might be a prevalent pathology in NSAP. Recently, we 
presented data that widespread sensory hypersensitivity along with localised neural tissue 
sensitivity were characteristic features in this condition [27]. Given these findings, it is not 
clear whether identification of a single specific pain classification can be achieved in NSAP.   
The purpose of this study was to (1) investigate the frequency of different pain classification 
in NSAP and (2) to investigate the clinical utility of three pain mechanism classification 
algorithms for NSAP. Specifically, we aimed to examine the completeness of classification 
and the inter-rater agreement for each classification algorithm. 
METHODS 
Study Design 
A cross-sectional observational study was conducted. Participants with NSAP underwent 
standardized assessment by a physiotherapist (NM). Assessment findings were then used by 
two physiotherapists (NM and TH) to classify participants according to three pain 
classification algorithms. The clinical utility of each algorithm was evaluated according to its 
capacity to completely classify all participants and by assessment of inter-rater agreement. 
Setting 
This study was set in a university laboratory. Participants were recruited from metropolitan 
hospitals, medical and physiotherapy practices and the general population. The study was 
approved by the Human Research Ethics Committee for Life Sciences, University College 
Dublin, and participating hospitals. All participants were unpaid volunteers who provided 
written informed consent. 
Participants 
Forty volunteers with arm pain, aged between 18-65 years were recruited. Participants were 
included if they had pain ≥3/10 of >3 months duration, who used desktop equipment for 
more than 40% of their working week [22] and had been employed using desk-top 
equipment for at least two years [28]. Participants were excluded if they had a diagnosed 
specific musculoskeletal condition or any of the following: generalized neurological or 
musculoskeletal disorders, low back pain or migraine over the previous 6 months, significant 
upper quadrant trauma, diabetes, endocrine disorders, epilepsy or significant mental health 
disorders. 
Investigators 
Clinical assessment of the participants and collection of baseline data and allocation of 
participants to pain classification groups was conducted by the lead author (NM). A second 
investigator (TH) independently verified assessment findings and independently allocated 
participants to pain classification groups. Data entry and analysis was conducted by a third 
investigator (AL). All investigators were physiotherapists with post-graduate qualification in 
musculoskeletal physiotherapy, with more than 11 years clinical experience and training in 
quantitative sensory testing (QST).    
Procedure 
Participants attended a one-off clinical assessment that included quantitative sensory 
testing (Figure 4). The diagnosis of ‘NSAP’ was confirmed by excluding alternative diagnoses 
including cervical referred pain and upper limb neuropathies (see Appendix 1). Neurological 
function and nervous system sensitisation (localised and widespread) was also assessed. 
Participants completed questionnaires to assess pain and disability.  Assessment findings 
were evaluated by two independent investigators. Participants were classified according to 
the three algorithms by two independent investigators (Figures 1-3). 
 Variables 
Variables used to classify participants for each algorithm were extracted from the patient 
history, written questionnaires, physical examination and QST findings. The interpretation of 
each variable within each classification algorithm is detailed in Table 1. 
History 
Variables extracted from the patient history included the presenting complaint, pain 
features, pattern of aggravating and easing factors, and signs and symptoms of nerve injury 
or compromise.  
Questionnaires 
Participants completed the Leeds Assessment for Neuropathic Symptoms and Signs (LANSS) 
questionnaire, Tampa Scale for Kinesiophobia (TSK) [29] [30], and Short-Form McGill Pain 
Questionnaire (SFMPQ) [31]. A LANSS of ≥12 was considered an indicator of possible 
neuropathic pain [32]. A TSK score of ≥37 was considered an indicator of significant fear 
avoidance beliefs [30]. In addition, the disability of arm, shoulder and hand (DASH) 
questionnaire was administered [34]. Pain descriptors in the MPQ, in addition to descriptors 
nominated by participants, and results from these questionnaires were used for completion 
of clinical algorithms (Table 1).  
Physical examination 
Physical examination included: 
 Neurological examination (reflexes, myotomes, dermatomes) [35] 
 Neural tissue sensitivity tests including the upper limb neurodynamic test 1 and 
palpation of the median, ulnar and radial nerves.  The neurodynamic test was 
considered positive if arm symptoms (at least in part) were reproduced along with 
positive structural differentiation tests [36, 37].   
 Assessment of pin-prick hyperalgesia and brush-stroke allodynia over symptomatic 
and remote asymptomatic regions   
 Assessment of general tenderness to light touch.  
Quantitative sensory testing 
A previously published QST protocol [38] was implemented to test the following:  cold, 
warm and vibration detection thresholds; cold, heat and pressure pain thresholds . All 
measures were recorded bilaterally over three upper limb sites. The tibialis anterior region 
was used as a remote reference point for thermal testing and pressure pain thresholds 
(recorded unilaterally). QST data were used during analyses for evidence of altered 
sensation either locally and/or at remote sites from the pain.  
Sensory phenotypes were determined for each participant by generating z-score profiles 
from QST data [39]. QST data were log transformed before calculation of z-scores. Z-
transformation for each variable was generated using the formula: Z-score = (X single 
participant – Mean controls) / SD controls [39]. Z-scores of > 2 z-scores from the mean were 
considered indicative of sensory gain to the tested stimuli, while z-scores of < 2 from the 
mean were considered indicative of sensory loss [40]. If a sensory abnormality was 
detected, it was sub-grouped as (a) localised, (b) localised within a neuroanatomical 
distribution or (c) widespread.   
Analyses 
Sample size was calculated using a method reported by Sim and Wright [41]. We considered 
that ᴋ= 0.40 would be the least clinically acceptable agreement measurement. Using the null 
hypothesis of ᴋ= 0.40 and assuming a 5% level of significance and a power of 0.8, a sample 
size of 39 was required. 
Participant characteristics and classification frequencies were analysed using descriptive 
statistics. Clinical utility of each algorithm was assessed according to the completeness of 
the classification according to each algorithm i.e. the proportion of participants classified 
versus unclassified. The Kappa coefficient was used to assess inter-rater agreement of 
classification according to each algorithm and was interpreted according to published 
guidelines [42].  
RESULTS 
Participant characteristics are presented in Table 2.  
Frequency of pain classification 
The frequency of assignment to each pain group and inter-rater agreement for each 
algorithm are presented in Tables 3, 4 & 5. The dominant pain classification was ‘unlikely 
neuropathic pain’ using the NeuPSIG algorithm, ‘peripheral nerve sensitisation’ using the 
Schafer algorithm, and ‘peripheral neuropathic pain’ using the Smart classification. 
Clinical Utility 
For two classification systems (NeuPSIG and Schafer algorithms) all but one participant 
could be classified by both observers. Using the Smart classification, 20% and 45% of 
participants were deemed to have mixed pain types by rater 1 and 2 respectively. 
A statistical coefficient of agreement was unattainable for the NeuPSIG algorithm; however, 
visual inspection of the data revealed excellent agreement between the observers (92% 
agreement). The inter-rater agreement was moderate at 40% for the Smart classification, 
which was set a priori as the minimal clinically-relevant acceptable agreement. Classification 
using the Schafer algorithm demonstrated good agreement at 78.3%. 
 
DISCUSSION 
This study demonstrates that  mechanisms-based pain classification algorithms developed 
for back pain +/- leg pain [8], low back related leg pain [14] and neuropathic pain [13] have 
potential clinical utility in the assessment of NSAP. Using the NeuPSIG algorithm, the most 
frequently allocated classification was ‘unlikely neuropathic pain’, while using the Smart and 
Schafer algorithms this was ‘peripheral neuropathic pain’ and ‘peripheral nerve 
sensitisation’ respectively. Between five and 11 participants were considered to have 
musculoskeletal/nociceptive pain using these latter algorithms, while few participants were 
deemed to have central or neuropathic sensitisation. The best agreement between raters 
was achieved using the Schafer algorithm. 
 
Pain Classifications in NSAP 
The results of this study indicate that NSAP may be considered a ‘peripheral neuropathic 
pain’ condition when using the Smart algorithm but was considered ‘unlikely neuropathic 
pain’ using the NeuPSIG algorithm [13]. This highlights discord in the clinical criteria used to 
classify neuropathic pain. The NeuPSIG algorithm requires that evidence of a lesion or 
disease of the nervous system is obtained through the history, pain distribution and further 
testing and provides a stepwise approach to the classification of neuropathic pain, from 
probable to definite. There are two key differences to the way we used the criteria outlined 
by [8] Firstly, because a hierarchy of the clinical criteria has not been indicated, all of the 
criteria were treated with equal weight when classifying patients. Secondly, signs and 
symptoms of neural tissue mechanosensitivity, even in the absence of neurological deficit, 
were assigned to peripheral neuropathic pain. This may explain the discrepancy between 
the results of the Smart classification and the NeuPSIG algorithm. Furthermore, the Schafer 
algorithm allows for separation of those with neurological deficit and those with neural 
tissue mechanosensitivity under the headings ‘denervation’ and ‘peripheral nerve 
sensitisation’; this resulted in 65% of participants falling into the latter category. The 
presence of peripheral nerve sensitisation in NSAP is consistent with our previous report 
[27] and other studies [22, 24, 43, 44]. These findings hold relevance for clinical decision 
making, discussed later in this paper.  
 
With respect to other classifications of pain, up to 28% of participants were classified as 
having nociceptive/musculoskeletal pain, but few were identified with widespread 
sensitisation (central or neuropathic sensitisation) (≤10%). The infrequent identification of 
widespread sensitisation in NSAP using these algorithms is surprising and contrasts with 
data from QST in this group that highlighted widespread sensitisation as a key characteristic 
[27]. To our knowledge, correlations between the clinical appraisal of the presence of 
widespread sensitisation and results from QST have not been yet been reported; however, 
quantitative measures of pain sensitivity have previously been shown to correlate poorly 
with self-reported pain and disability [45]. Hübscher et al. (2013) proposed one reason for 
this poor correlation may be the fact that none of the included studies in that review 
specifically recruited people deemed clinically to present with widespread sensitisation and 
as such, correlations between QST and clinical presentation of pain may have been diluted. 
Interestingly, while widespread hypersensitivity is acknowledged as an important 
mechanism underpinning some chronic pain states e.g. whiplash and fibromyalgia [46-48], 
both its status as a distinct pain classification and criteria for its classification are not yet 
fully established.  
Appraisal of each algorithm 
In consideration of the NeuPSIG algorithm, it is unsurprising that the majority of the 
participants were deemed unlikely to have neuropathic pain, with only three participants 
allocated to the ‘possible’ category by one observer. No participant was classified as 
probable or definite in this group. Our participants were screened for the presence of 
specific diagnoses prior to inclusion in this study, and neurological injury would have meant 
exclusion. The NeuPSIG algorithm was therefore accurate in this respect; however, its use 
may have been redundant in this group. The purpose of the NeuPSIG algorithm is to provide 
a framework for classification of neuropathic pain, which relies on the diagnosis of  
neuropathy [13]. There has been some debate about this approach and a view that 
neuropathic pain may be a broader entity [49]. Nonetheless, the benefit of this algorithm 
for guiding clinical decision making in primary care lies in its ability to identify patients who 
may warrant further investigation or more specific management for neuropathy [50]. The 
limitation of this algorithm is that in the absence of neuropathic pain, other guidelines are 
required for further classification and direction for management. 
The Smart classification resulted in the highest number of participants classified with mixed 
pain presentations and the lowest consistency between raters. This was largely influenced 
by the number of participants classified as mixed by one rater. Improvement in inter-rater 
agreement might be achieved with more specific instruction about interpreting assessment 
findings in light of the classification criteria. Inter-rater agreement in the current study are 
considerably lower than previously reported [51]; however, that study used different 
methodology. [51] assessed agreement of a larger suite of clinical criteria items that were 
used in an earlier phase of their study. Further, [51] tested decisions made immediately 
following patient assessment rather than post-hoc as they were in this study. The clinical 
criteria for selection in each category incorporates a combination of subjective and 
objective features, the absence of a hierarchical model meant that many participants were 
classified as ‘mixed’. Whilst this makes clinical decision making difficult, it may reflect the 
real-life clinical situation, where patients are likely to present with a mix of pain types and 
where pain states are a continuum rather than discrete entities. However, developing this 
classification system into a stepwise clinical algorithm might be beneficial.  
The dominant classification of the Smart classification was peripheral neuropathic pain 
despite this cohort being screened and cleared of neuropathy. The inclusion of both 
neurological deficit and signs and symptoms of neural tissue mechanosensitivity within the 
same category in this algorithm diminishes the capacity of this algorithm to guide clinical 
decision making as it is necessary to segregate those with neurological deficit from those 
without for the purpose of guiding further investigation and possible treatment.  
 
The Schafer algorithm was considered the most clinically useful algorithm for NSAP, both 
due to the high number of people classified and the good inter-rater agreement.  This is 
likely due to two factors; firstly the hierarchical nature of the algorithm forces a category 
selection that is based on limited but key information. Secondly, the presence of a separate 
category for neural tissue mechanosensitivity i.e. peripheral nerve sensitisation was useful 
in NSAP. The identification of peripheral nerve sensitisation as a distinct category may be 
controversial from a mechanisms-based pain classification perspective. As is apparent from 
the Smart classification, it has become common to describe neural tissue 
mechanosensitivity as a neuropathic pain condition. This description reflects the 
inconsistency across some disciplines in the semantic use of the term 'neuropathic'. Whilst 
neural tissue provocation tests have demonstrated validity [52, 53], whether peripheral 
nerve sensitisation is a discrete neuropathic pain condition is debatable. Certainly, neural 
tissue sensitisation frequently occurs with painful neuropathies [54]; however, in the 
absence of a distinct neuropathy, a number of mechanisms to explain sensitisation of neural 
tissue include neuritis [55, 56], sensitisation of nervi nervorum [57] and minor neuropathy 
[22]. Regardless of the semantic arguments, arm pain with neuropathy and arm pain 
without neuropathy but with neural tissue sensitivity usually require different treatment 
approaches so distinguishing between these conditions is important.  
 
Clinical value of pain classification algorithms  
It is important to consider how pain classification might influence clinical decision-making. 
From the algorithms outlined, four sub-groups are evident: (1) Neuropathic pain; (2) 
Musculoskeletal pain; (3) Widespread sensitisation and (4) Peripheral nerve sensitisation 
(i.e. localised neural tissue mechanosensitivity). An important caveat in discussing sub-
grouping is whether it results in improved outcomes. Whilst sub-grouping is attractive for 
the stratification of healthcare and appears logical, as will be outlined, the impact of sub-
grouping on treatment outcomes is, as yet, inconsistent [58-60]. 
Neuropathic pain: A key task when triaging a patient is the identification of specific 
pathologies including neuropathy ±neuropathic pain. Such patients often require specific 
investigations and sometimes surgical intervention [50]. Conservative management in this 
group including physical therapies [61], and anti-convulsant medications [62] might also be 
considered. 
Musculoskeletal pain: The identification of musculoskeletal (nociceptive) pain, in the 
absence of neuropathy or central sensitisation, suggests that clinicians should focus on 
conservative interventions, such as, education, simple analgesic/ anti-inflammatory 
medication and physical treatments such as exercise and manual therapy [63-66]. 
Widespread sensitisation: Widespread sensitisation involves peripheral and central nervous 
system sensitisation which poses a particular challenge in clinical practice. There is growing 
research evidence that many people with chronic musculoskeletal conditions display signs 
of widespread sensitisation [47, 48, 67-70]. Evidence based management approaches 
remain elusive in this group [47, 59]; however, comprehensive, multi-disciplinary 
approaches incorporating pain science education, are likely warranted [70, 71].  
Peripheral nerve sensitisation: The mechanisms underpinning peripheral nerve sensitisation 
are still open to debate. Nonetheless, identification of peripheral nerve sensitisation as a 
distinct entity is potentially beneficial. Emerging data demonstrate positive responses to 
therapies specifically targeting neural tissue sensitivity i.e. non-provocative neural 
mobilisation [6, 72-74] in those classified with peripheral nerve sensitisation. 
 Study Limitations 
Further studies on a larger sample size and by researchers who have not been involved in 
the development of the classification systems is warranted.  
 
CONCLUSION 
This study explored the clinical utility for NSAP of three pain algorithms that classify patients 
according to pain mechanisms. The results indicate that the NeuPSIG algorithm is effective 
in identifying those with neuropathic pain resulting from an identifiable neurological lesion. 
The Schafer algorithm was demonstrated to have the best clinical utility in terms of number 
of participants classified and inter-rater agreement. Finally the Smart classification resulted 
in the most participants classified with ‘mixed pain’ in this cohort, which also largely 
accounted for the lower inter-rater rates using this method. The results from this study 
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